After Today’s Bearish Options Activity, Is iShares NASDAQ Biotechnology Index (ETF)’s Near-Term Analysis Positive?

 After Today's Bearish Options Activity, Is iShares NASDAQ Biotechnology Index (ETF)'s Near Term Analysis Positive?

In today’s session iShares NASDAQ Biotechnology Index (ETF) (IBB) recorded an unusually high (4,032) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the November, 2016 put, expecting serious IBB decrease. With 4,032 contracts traded and 1974 open interest for the Nov, 16 contract, it seems this is a quite bearish bet. The option with symbol: IBB161118P00245000 closed last at: $2.75 or 1.8% down. About 861,841 shares traded hands. iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) has risen 1.77% since March 14, 2016 and is uptrending. It has underperformed by 3.84% the S&P500.

iShares Nasdaq Biotechnology ETF , formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The ETF has a market cap of $6.87 billion. The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). It has a 2.94 P/E ratio. The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

IBB Company Profile

iShares Nasdaq Biotechnology Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index consists of securities of NASDAQ-listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, and which also meet other eligibility criteria. The Index is one of the eight sub-indices of the NASDAQ Composite, which measures all common stocks listed on The NASDAQ Stock Market, Inc.

More notable recent iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) news were published by: Investorplace.com which released: “The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is at a Critical Level” on October 17, 2016, also Profitconfidential.com with their article: “iShares NASDAQ Biotechnology ETF: Has IBB Stock Finally Bottomed?” published on July 17, 2016, Investorplace.com published: “Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Turning …” on September 21, 2016. More interesting news about iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) were released by: Etfdailynews.com and their article: “Biotech ETFs Have Room to Run, with Several Catalysts Ahead” published on September 30, 2016 as well as Livetradingnews.com‘s news article titled: “iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) Heffx Trading Outlook” with publication date: October 13, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment